Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
The innovation leverages Mitsui Chemicals’ oxygen-permeable InnoCell cell culture plate to efficiently collect bile while reducing stress on liver cells
Chemicals delivered improved efficiency and optimal capacity utilization, with EBIT rising 37% YoY
The capital was raised via multiple-tenure non-convertible debentures (NCDs) and commercial papers
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
Speakers for the Session are: Venkata Prasad K., Unit Head, Deepak Nitrite; Abhilash Pasham, Associate General Manager - Central Engineering & Projects, Dr. Reddy's Laboratories; C. V. Rajulu, Consultant, Industry; and Jyoti Shankar Jha, Senior Lead Scientist, Alleima India. The moderator for the Session is Pravin Prashant, Executive Editor, Indian Pharma Post
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
